Roche Holding AG isn’t done making moves in the obesity market after last month’s agreement to buy Carmot Therapeutics Inc. for as much as $3.1 billion (CHF2.64 billion).
This content was published on
2 minutes
Bloomberg
The Swiss drugmaker said on Tuesday that it’s on the hunt for additional biotech partners to help it challenge weight-loss leaders Novo Nordisk A/S and Eli Lilly & Co. Roche is looking for new ways of adjusting metabolism that could ultimately be combined with treatments it’s gaining in the Carmot deal.
“This is opening up a whole new vista for us,” James Sabry, Roche’s head of partnering, said in an interview on the sidelines of the JPMorgan Healthcare Conference in San Francisco.
More
More
Roche declares war on obesity with billion-dollar takeover
This content was published on
Pharmaceutical company Roche is entering the fight against obesity with the $2.7 billion takeover of United States firm Carmot Therapeutics.
Carmot was one in a flurry of recent deals Roche has made to bolster its pipeline. The company is also interested in oncology, neurology and ophthalmology as well as cardiovascular medicine, Sabry said.
While many companies are trying to break into the hot weight-loss market, Sabry said Roche is one of only a handful of suitors with the size and global reach to run the large, costly trials necessary to bring new drugs to market. Marketing obesity medicines is also more complicated than other areas like cancer because drugmakers need to deal with primary-care doctors instead of a few specialised treatment centres, he said.
More
More
What lies ahead for Switzerland: the economic outlook for 2024
This content was published on
SWI swissinfo.ch journalists select the major developments that await the Swiss economy in 2024.
“When we’re trying to get a deal done, we find more competitors in oncology,” he said. “You’d think everyone must be competing with you for metabolism drugs, but it’s not that way.”
Roche was one of the first pharmaceutical companies to work on an experimental drug in the GLP-1 class, a category that includes Novo’s Wegovy and Lilly’s Zepbound. But it halted development more than a decade ago after patients dropped out of a study due to side effects such as nausea.
Swiss-EU negotiations on ‘last mile’, says Swiss foreign minister
This content was published on
Discussions with the European Union on how to re-forge relations with Switzerland are at an advanced stage, according to Swiss foreign minister Ignazio Cassis.
This content was published on
It is not necessary to define Swiss neutrality more strictly, according to the Swiss government. The Federal Council has rejected the so-called “neutrality initiative”.
Swiss government to improve disaster alert system via mobile phones
This content was published on
The Federal Council wants to modernise the disaster warning system for the population with alerts sent via the mobile phone network and other digital channels.
Poll: most Swiss believe littering is steadily decreasing
This content was published on
Littering is steadily decreasing in Switzerland, according to an annual survey conducted by the Swiss Center of Excellence against Littering.
This content was published on
The Federal Criminal Court has acquitted UBS following appeal proceedings in connection with money laundering charges linked to the Bulgarian mafia. The bank inherited the case from Credit Suisse.
This content was published on
The Swiss Federal Railways (SBB/CFF) timetable change on December 15 will bring improvements for commuters. It will also have new night-time connections on long-distance and regional services.
Swiss launch healthcare initiative to improve working conditions of doctors and nurses
This content was published on
The Swiss authorities have launched an initiative to promote healthcare centres and improve working conditions for doctors, nurses and pharmacists.
Morges fatal shooting: police officer acted in self-defence, prosecutors conclude
This content was published on
The police officer who shot dead a black man at Morges train station in western Switzerland in 2021 acted in self-defence, the Office of the Attorney General of canton Vaud have concluded.
This content was published on
Switzerland has welcomed the announcement of a ceasefire deal between Israel and the Iran-backed group Hezbollah in Lebanon.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.